Scientists Find Potential Targets for COVID-19 VaccineJune 3, 2020
Scientists from the University of Manchester (UoM) have identified parts of the SARS-CoV-2 coronavirus that activate an immune response and which could act as targets for vaccine development. The small scale study published in Annals of Rheumatic Diseases used new technology to analyze the total immune response in patients with dermatomyositis, a musculoskeletal disease and identified a link to lifetime exposure to coronavirus infection.
The team used a novel unbiased method to identify antibodies produced by the immune system against all types of infection that were unique or enriched in individuals with dermatomyositis, compared to healthy patients, during their lifetime.
In patients with autoimmune dermatomyositis, the UoM team identified three specific sections of the bat coronavirus proteins that stimulated an immune response that was highly similar to the human SARS-CoV-2 virus that causes COVID-19 disease. These sections may indicate SARS-CoV-2 targets for vaccine development against COVID-19.
You might also like:
- First Human Trial of COVID-19 Vaccine Found Safe and Induces Rapid Immune Response
- Medicago Announces Positive Results of Trials for its COVID-19 Vaccine Candidate
- Researchers Discover Antibody that Blocks SARS-CoV-2 Infection in Cells
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- Zambia to Release 2 Drought Tolerant Cowpea Varieties
- Genome Editing and Its Applications in Health and Agriculture
- Chile Serves as a Key Enabler for Global Plant Breeding Innovations
- Omega-3 Canola Oil to Help Reduce Overfishing
- Bt Brinjal Farmers Earned 21.7% More, Satisfied with Yield and Crop Quality
- Plant Science Discovery Uncovers Ways to Improve Immune Responses
- Iranian GM Rice Found to Contribute to Environmental Health
- GA20ox-2 Targeted Mutation Produces Semi-dwarf Rice
- Scientists Find Potential Targets for COVID-19 Vaccine
- First Results from Human COVID-19 Immunology Study Identify Universally Effective Antibodies
Read the latest:
- Biotech Updates (November 29, 2023)
- Gene Editing Supplement (November 29, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: